• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉、腹腔或盆腔内给药后门静脉血和外周血中丝裂霉素C的浓度

[Concentration of mitomycin C in portal blood and peripheral blood after intra venous, intraperitoneal or intrapelvic administration].

作者信息

Sato Y, Ohtsuka K, Ono K

机构信息

Dept. of Surgery, Okayama Red Cross General Hospital.

出版信息

Gan To Kagaku Ryoho. 1993 Jan;20(1):131-6.

PMID:8422177
Abstract

Immediately before closing the abdomen in a curative operation for colorectal cancer, 20 mg of Mitomycin C (MMC) was administered by intravenous, intraperitoneal or intrapelvic routes, and portal blood and peripheral blood were simultaneously collected to investigate the disposition of MMC. After intravenous administration, the MMC concentration in portal and peripheral bloods changed at the same levels, showing a biphasic pattern. The maximum concentration (Cmax) seen shortly after administration was about 2 micrograms/ml. The blood halflife in phase alpha was about 5 min, and that in phase beta about 30 min. After intraperitoneal administration, the MMC concentration in portal blood was over 60 min higher than that in peripheral blood. Cmax in portal blood, seen within 5 min after administration, was about 0.5 micrograms/ml, and that in peripheral blood was about 0.2 micrograms/ml around 10 min. The half-life was about 30 min in both types of blood. After intrapelvic administration, the MMC concentration in portal blood changed at higher levels than in peripheral blood, as after intraperitoneal administration. The Cmax in portal blood, obtained within about 5 min, was about 0.3 micrograms/ml, and that in peripheral blood was about 0.1 micrograms/ml at 12 min. The half-life was about 30 min in both types of blood. As described above, the disposition of MMC was investigated on the basis of the concentration in portal and peripheral blood. As a result, intravenous MMC showed a similar change, whereas intraperitoneal or intrapelvic MMC was higher in portal blood than in peripheral blood, indicating that the disposition of MMC was different with the route of administration.

摘要

在对结直肠癌进行根治性手术即将关闭腹腔前,通过静脉、腹腔或盆腔内途径给予20毫克丝裂霉素C(MMC),并同时采集门静脉血和外周血以研究MMC的处置情况。静脉给药后,门静脉血和外周血中的MMC浓度以相同水平变化,呈现双相模式。给药后不久出现的最大浓度(Cmax)约为2微克/毫升。α相的血液半衰期约为5分钟,β相约为30分钟。腹腔给药后,门静脉血中的MMC浓度比外周血高60多分钟。给药后5分钟内门静脉血中的Cmax约为0.5微克/毫升,外周血中的Cmax在10分钟左右约为0.2微克/毫升。两种血液中的半衰期均约为30分钟。盆腔内给药后,门静脉血中的MMC浓度变化与腹腔给药后一样,高于外周血。给药后约5分钟获得的门静脉血中的Cmax约为0.3微克/毫升,外周血中的Cmax在12分钟时约为0.1微克/毫升。两种血液中的半衰期均约为30分钟。如上所述,根据门静脉血和外周血中的浓度对MMC的处置情况进行了研究。结果表明,静脉注射MMC呈现相似变化,而腹腔或盆腔内注射MMC时门静脉血中的浓度高于外周血,这表明MMC的处置情况因给药途径而异。

相似文献

1
[Concentration of mitomycin C in portal blood and peripheral blood after intra venous, intraperitoneal or intrapelvic administration].静脉、腹腔或盆腔内给药后门静脉血和外周血中丝裂霉素C的浓度
Gan To Kagaku Ryoho. 1993 Jan;20(1):131-6.
2
[Portal blood levels of mitomycin C after intraperitoneal administration].腹腔注射后丝裂霉素C的门静脉血药浓度
Gan To Kagaku Ryoho. 1992 Aug;19(10 Suppl):1713-5.
3
[Blood levels of mitomycin C in patients given by various routes of administration].[不同给药途径患者的丝裂霉素C血药浓度]
Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 1):2639-44.
4
Pharmacokinetics of intra-arterial mitomycin C in the chemoembolization treatment of liver metastases with polyvinylalcohol or degradable starch microspheres.丝裂霉素C动脉内给药联合聚乙烯醇或可降解淀粉微球化疗栓塞治疗肝转移瘤的药代动力学
Eur J Clin Pharmacol. 2002 Oct;58(7):459-65. doi: 10.1007/s00228-002-0496-8. Epub 2002 Sep 5.
5
Pharmacokinetic studies of intraaortic stop-flow infusion with 14C-labeled mitomycin C.14C标记丝裂霉素C的主动脉内停流输注的药代动力学研究。
J Surg Res. 1995 Sep;59(3):415-9. doi: 10.1006/jsre.1995.1184.
6
[Pharmacokinetics and prophylactic effect of intraperitoneal administration of mitomycin C resulting in IC50 of gastric cancer].
Gan To Kagaku Ryoho. 1990 Aug;17(8 Pt 2):1541-5.
7
Penetration of mitomycin C in human bladder.丝裂霉素C在人膀胱中的渗透情况。
Cancer Res. 1993 Jul 15;53(14):3314-20.
8
Pharmacokinetic analysis in intraperitoneal hyperthermic chemotherapy of far-advanced gastric cancer patients.进展期胃癌患者腹腔热灌注化疗的药代动力学分析
Gan No Rinsho. 1989 Aug;35(9):1016-20.
9
[Study of disposition of adriamycin and mitomycin C in liver by determination of plasma concentrations in hepatic vein and artery during intravenous constant infusion in rats].[通过测定大鼠静脉恒速输注期间肝静脉和动脉中的血浆浓度研究阿霉素和丝裂霉素C在肝脏中的处置情况]
Gan To Kagaku Ryoho. 1997 Jun;24(8):975-9.
10
Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.奥沙利铂联合5-氟尿嘧啶、亚叶酸钙和丝裂霉素C进行肝动脉灌注:奥沙利铂的药代动力学及可行性
Anticancer Res. 2003 Nov-Dec;23(6D):5203-8.